| Literature DB >> 34579667 |
Mariana Velleca1, Mohsen Malekinejad2,3, Cecily Miller2,4, Lucia Abascal Miguel2, Hailey Reeves2, Philip Hopewell1, Elizabeth Fair5,6.
Abstract
BACKGROUND: Contact investigation, the systematic evaluation of individuals in close contact with an infectious tuberculosis (TB) patient, is a key active case-finding strategy for global TB control. Better estimates of the yield of contact investigation can guide strategies to reduce the number of underreported and underdiagnosed TB cases, approximately three million cases per year globally. A systematic review (Prospero ID # CRD42019133380) and meta-analysis was conducted to update and enhance the estimates of the yield of TB contact investigation in low- and middle-income countries (LMIC). Pubmed, Web of Science, Embase and the WHO Global Index Medicus were searched for peer-reviewed studies (published between January 2006-April 2019); studies reporting the number of active TB or latent tuberculosis infection (LTBI) found through contact investigation were included. Pooled data were meta-analyzed using a random effects model and risk of bias was assessed.Entities:
Keywords: Contact investigation; Mycobacterium tuberculosis; Systematic Review; Tuberculosis
Mesh:
Year: 2021 PMID: 34579667 PMCID: PMC8474777 DOI: 10.1186/s12879-021-06609-3
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Flow diagram for study selection
Fig. 2Distribution of studies per year based on the start date of data collection (n = 110). *: there was no information on the start date of data collection, but the publication of these studies was before September 2012
Fig. 3Overall results of the risk of bias assessment (n = 110)
Fig. 4Forest plot of the yield of contact investigations for all active tuberculosis (confirmed and clinically/ radiologically diagnosed)
Fig. 5Forest plot of the yield of contact investigations for confirmed tuberculosis
Fig. 6Forest plot of the yield of contact investigations for LTBI
Pooled yields among subgroups for all active TB, confirmed active TB, and LTBI
| Subgroups | n | Pooled % yield for all active TB (95% confidence interval) | n | Pooled % yield for confirmed active TB (95% confidence interval) | n | Pooled % yield for LTBI (95% confidence interval) |
|---|---|---|---|---|---|---|
| WHO Geographic regions | ||||||
| AFR | 37 | 3.43% (2.91–3.94, I2 97.09%) | 27 | 1.97% (1.62–2.31, I2 94.58%) | 15 | 44.14% (32.52–55.76, I2 99.62%) |
| AMR | 12 | 2.68% (1.95–3.41, I2 94.70%) | 5 | 4.77% (2.02–7.51, I2 78.37) | 6 | 56.74% (45.78–67.69, I2 98.31%) |
| EMR | 10 | 3.11% (2.33–3.90, I2 97.29%) | 7 | 2.98% (2.13–3.82, I2 94.48%) | 6 | 39.43% (27.23–51.62, I2 95.94%) |
| EUR | 3 | 2.30% (1.69–2.91)* | 1 | 1.73% (1.05–2.83)* | 2 | 38.44% (36.06–40.82)* |
| SEAR | 12 | 4.81% (3.42–6.21, I2 93.53%) | 8 | 2.93% (1.59–4.27, I2 94.77%) | 7 | 45.63% (26.66–64.60, I2 99.31%) |
| WPR | 14 | 1.17% (0.75–1.59, I2 98.58%) | 10 | 0.94% (0.42–1.46, I2 99.04%) | 6 | 32.58% (23.38–41.79, I2 97.90%) |
| World Bank income classification | ||||||
| Low-income | 28 | 3.00% (2.49–3.52, I2 97.70%) | 21 | 1.97% (1.5–2.44, I2 97.04%) | 13 | 46.89% (34.23–59.54, I2 99.67%) |
| Lower middle-income | 30 | 3.29% (2.74–3.84, I2 96.83%) | 21 | 2.23% (1.69–2.76, I2 95.62%) | 16 | 44.85% (34.57–55.13, I2 98.79%) |
| Upper middle-income | 30 | 2.22% (1.86–2.58, I2 97.52%) | 16 | 1.78% (1.40–2.16, I2 96.73%) | 13 | 39.34% (32.15–46.54, I2 98.73%) |
| Year started data collection | ||||||
| Pre WHO guideline | 63 | 2.77% (2.47–3.08, I2 97.97%) | 38 | 1.99% (1.67%-2.31%, I2 98.34%) | 39 | 45.22% (39.25–51.19, I2 99.40%) |
| Post WHO guideline | 25 | 3.08% (2.49–3.68, I2 96.33%) | 20 | 2.10% (1.57–2.64, I2 95.09%) | 3 | 25.80% (18.19–33.40)* |
| HIV status | ||||||
| Positive contacts | 9 | 8.95% (5.49–12.41, I2 80.53%) | 5 | 6.71% (2.15–11.27, I2 89.11%) | 0 | N/A |
| Sputum smear status of index case | ||||||
| Positive sputum smear index | 5 | 8.30% (3.88–12.73, I2 85.36%) | N/A | N/A | N/A | N/A |
| MDR-TB | ||||||
| Contacts of MDR-TB | 13 | 4.69% (3.26–6.13, I2 94.30%) | 10 | 3.43% (2.05–4.82, I2 90.28%) | 7 | 37.53% (24.22–50.84, I2 95.99%) |
| Location of contact investigation | ||||||
| Community-based | 36 | 2.34% (1.96–2.72, I2 97.89%) | 28 | 2.14% (1.72–2.55, I2 97.96%) | 17 | 46.67% (36.86–56.49, I2 99.64%) |
| Clinic-based | 38 | 3.44% (2.96–3.93, I2 97.93%) | 24 | 1.90% (1.37–2.43, I2 98.03%) | 20 | 40.15% (32.81–47.49, I2 98.18%) |
AFR Africa, AMR Americas, EMR Eastern Mediterranean, EUR Europe, SEAR South-East Asia, WPR Western Pacific
*Due to small study size it was not possible to assess heterogeneity
Pooled data for all active TB and confirmed active TB among contacts, by age group
| Subgroups | Studies (n) | Pooled % yield (95% confidence interval) |
|---|---|---|
| All active TB | ||
| < 5y | 32 | 6.84% (5.56–8.11, I2 95.95%) |
| 5–14y | 11 | 3.13% (2.11–4.16, I2 85.81%) |
| < 15y | 28 | 3.59% (2.72–4.46, I2 95.30%) |
| ≥ 15y | 26 | 3.69% (3.0–4.37, I2 91.81%) |
| Confirmed active TB | ||
| < 5y | 10 | 0.73% (0.24–1.22, I2 79.03%) |
| 5–14y | 5 | 3.43% (1.02–5.85, I2 76.27%) |
| < 15y | 15 | 1.65% (1.03–2.27, I2 86.85%) |
| ≥ 15y | 20 | 3.22% (2.27–4.17, I2 91.23%) |